好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Poster Session 03

Tuesday 04/15/08
04:00 PM - 07:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Neuro-oncology, Aging and Dementia, Anterior Horn, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Ethics, Pain and Palliative Care, Headache, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neural Repair/Rehabilitation, Neurogenetics and Gene Therapy, Peripheral Nerve
No CME available
Event Timeline
04:00 PM - 07:30 PM Abstract 001 - Quality of Life in Children with Epilepsy as Measured by the Peds QL[trade]
04:00 PM - 07:30 PM Abstract 002 - CT and MRI Neuroimaging Findings in Children Who Present with Afebrile New Onset Seizures
04:00 PM - 07:30 PM Abstract 003 - Does Sleep Prior to the EEG Matter in Children? A Randomized, Blinded Study
04:00 PM - 07:30 PM Abstract 004 - Intravenous Levetiracetam Achieves Expected Serum Levels in Critically Ill Children
04:00 PM - 07:30 PM Abstract 005 - Narcolepsy with Cataplexy as an Early Symptom of Occult Neuroblastoma
04:00 PM - 07:30 PM Abstract 006 - Febrile Seizure Management in Hospital Practice Compared to Guidelines
04:00 PM - 07:30 PM Abstract 007 - Impact of BCG Vaccination on Neuroimaging Findings and Outcome in Pediatric CNS Tuberculosis
04:00 PM - 07:30 PM Abstract 008 - A Study of Intrathecal Baclofen Pumps in Children: Experience from a Tertiary Care Center
04:00 PM - 07:30 PM Abstract 009 - Reliability and Validity of the PedsQL[trade] Neuromuscular Module 1.0 in the Duchenne Muscular Dystrophy Population
04:00 PM - 07:30 PM Abstract 010 - Long-Term Effects of Neonatal Pain on Later Life Pain Behavior: Can They Be Modulated?
04:00 PM - 07:30 PM Abstract 011 - Ventricular Wall Granulations Facilitate Cerebrospinal Fluid Flow in Chronic Hydrocephalus
04:00 PM - 07:30 PM Abstract 012 - Case Report of the Phenotype and Treatment of a Child with Novel Mutations of the Tyrosine Hydroxylase Gene
04:00 PM - 07:30 PM Abstract 013 - Acute Facial Palsy (Bell's Palsy) in Children
04:00 PM - 07:30 PM Abstract 014 - Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Children: Study of 20 Cases
04:00 PM - 07:30 PM Abstract 015 - Long Term Follow Up of Children with Chronic Demyelinating Polyneuropathy: Variability of Clinical and Electrophysiological Course and Treatment Outcome
04:00 PM - 07:30 PM Abstract 016 - Premorbid Neurological and Neurocognitive Impairment Is Predominant in Younger Children with Acquired Demyelinating Disorders
04:00 PM - 07:30 PM Abstract 017 - Screening Visual Motor and Perceptual Abnormalities in Children with Demyelinating Disorders
04:00 PM - 07:30 PM Abstract 018 - Childhood Multiple Sclerosis - Center Based Analysis of 22 Cases
04:00 PM - 07:30 PM Abstract 019 - Neuromyelitis Optica in Children
04:00 PM - 07:30 PM Abstract 020 - MS Onset before Puberty: A Distinct MRI Phenotype?
04:00 PM - 07:30 PM Abstract 021 - A Functional MRI Study of Patients with Pediatric Multiple Sclerosis
04:00 PM - 07:30 PM Abstract 022 - MRI Findings in Pediatric-Onset Multiple Sclerosis Patients: A Retrospective Study
04:00 PM - 07:30 PM Abstract 023 - Objective and Subjective Cognitive and Psychosocial Functioning in Childhood Onset Demyelinating Disorders
04:00 PM - 07:30 PM Abstract 024 - Presentation, Course and Outcome of Multiple Sclerosis in Children under 10 Years of Age
04:00 PM - 07:30 PM Abstract 025 - Biomarker Discovery in MS: A Proteomic Approach
04:00 PM - 07:30 PM Abstract 026 - Long Lesions on Initial Spinal Cord MRI Predict a Final Diagnosis of Acute Disseminated Encephalomyelitis Versus Multiple Sclerosis in Children
04:00 PM - 07:30 PM Abstract 027 - Racial and Ethnic Findings in Pediatric MS: An Update
04:00 PM - 07:30 PM Abstract 028 - Clinical Spectrum of Pediatric CNS Demyelinating and Related Disorders at Children's Hospital of Michigan, Detroit
04:00 PM - 07:30 PM Abstract 029 - Pediatric MS Onset: A Distinct Phenotype Influenced by Ethnicity?
04:00 PM - 07:30 PM Abstract 030 - Childhood Onset Multiple Sclerosis Has Worse Prognosis Than Adult Onset MS on the Basis of Cognition and Magnetic Resonance Imaging Findings
04:00 PM - 07:30 PM Abstract 031 - A Tetracycline That Corrects SMN2 Splicing for Potential Therapy of Spinal Muscular Atrophy (SMA)
04:00 PM - 07:30 PM Abstract 032 - Constitutive Role of Mitochondria in Spinal Muscular Atrophy (SMA)
04:00 PM - 07:30 PM Abstract 033 - Proteasome Inhibition in Spinal Muscular Atrophy
04:00 PM - 07:30 PM Abstract 034 - An Analysis of Disease Severity Based on SMN2 Copy Number in Adults with Spinal Muscular Atrophy
04:00 PM - 07:30 PM Abstract 035 - Phosphorylation of Survival of Motor Neuron (SMN) Protein and Its Potential Importance in SMN Function and Stability
04:00 PM - 07:30 PM Abstract 036 - A Comparison of Serum Creatinine Kinase (CK) Levels in Spinobulbar Muscular Atrophy (SBMA) and Amyotrophic Lateral Sclerosis (ALS)
04:00 PM - 07:30 PM Abstract 037 - Identification of an X-Linked Distal Spinal Muscular Atrophy Locus
04:00 PM - 07:30 PM Abstract 038 - Difficulties in Making a Diagnosis of Hirayama Disease in Caucasian Children
04:00 PM - 07:30 PM Abstract 039 - Water Turnover in ALS Measured by the Doubly Labeled Water Method
04:00 PM - 07:30 PM Abstract 040 - Quantitative Sit-to-Stand [STSv], Walking [WLKv] and 360 Degree Axial Rotation [AXRv] Velocity in Amyotrophic Lateral Sclerosis [ALS] and Multiple Sclerosis [MS] Patients - Prospective Natural History and Correlation with Falls, Adaptive Equipment Needs and Survival
04:00 PM - 07:30 PM Abstract 041 - Neuroprotective Effect of the Iron Chelator Desferoxamine on Myelomonocytes from Sporadic ALS Patients Subjected to Hypoxic Stress: Implications for Therapy
04:00 PM - 07:30 PM Abstract 042 - Pain in ALS Patients
04:00 PM - 07:30 PM Abstract 043 - A Population Based Survey of Cognitive Decline in ALS
04:00 PM - 07:30 PM Abstract 044 - The Diagnosis of ALS-FTD: Comparison of Caregiver and Patient Behavioral Ratings
04:00 PM - 07:30 PM Abstract 045 - Prospective Study of Circumstances and Causes of Death in ALS
04:00 PM - 07:30 PM Abstract 046 - Respiratory Factors and Outcome in Amyotrophic Lateral Sclerosis
04:00 PM - 07:30 PM Abstract 047 - Diaphragm EMG Measurements Utilizing Implanted Electrodes of the Diaphragm Pacing Stimulation (DPS) System: Advancing Our Understanding of Respiration in ALS
04:00 PM - 07:30 PM Abstract 048 - Do Dyspnea Scales Correlate with Pulmonary Function in ALS?
04:00 PM - 07:30 PM Abstract 049 - Classical Twin Prevalence Studies in Multiple Sclerosis: Time To Stop?
04:00 PM - 07:30 PM Abstract 050 - Traumatic Brain Injury May Precipitate Rapidly Progressive Cerebral Form of Adrenoleukodystrophy
04:00 PM - 07:30 PM Abstract 051 - Molecular Study of Three Tunisian Families with L-2-Hydroxyglutaric Aciduria
04:00 PM - 07:30 PM Abstract 052 - Molecular Characterization of Adult Onset Cerebral X-Linked Adrenoleukodystrophy
04:00 PM - 07:30 PM Abstract 053 - A Case Report of Hereditary Spastic Paraplegia with Thin Corpus Callosum
04:00 PM - 07:30 PM Abstract 054 - Voxel-Based Morphometry Shows Deep White Matter Damage in Friedreich Ataxia
04:00 PM - 07:30 PM Abstract 055 - Identification of a New Form of Autosomal Dominant Hereditary Spastic Paraplegia (HSP)
04:00 PM - 07:30 PM Abstract 056 - Molecular Genetic Analysis of SPG6/NIPA1 Hereditary Spastic Paraplegia
04:00 PM - 07:30 PM Abstract 057 - Familial Hemifacial Spasm: An Unique Occurrence of Five Female Cases in One Czech Family
04:00 PM - 07:30 PM Abstract 058 - Whole-Genome Scan Association Study in Primary Progressive Multiple Sclerosis (PPMS)
04:00 PM - 07:30 PM Abstract 059 - A Novel Comprehensive Diagnosing System for Mitochondrial DNA Mutations Using Suspension Array Technology
04:00 PM - 07:30 PM Abstract 060 - The Transfer RNAGlycine A10044G Mitochondrial DNA (mtDNA) Mutation: A Complex Role in Producing Mitochondrial Disease
04:00 PM - 07:30 PM Abstract 061 - Alteration in the Copy Number of Mitochondrial DNA in Leukocytes of Patients with Mitochondrial Encephalomyopathies
04:00 PM - 07:30 PM Abstract 064 - Alu-Element Insertion in the OPA1 Intron Sequence Associated with ADOA
04:00 PM - 07:30 PM Abstract 065 - Clinical and Laboratory Features of a Novel Mutation in the ATP8 Gene of the Mitochondrial DNA (mtDNA): G8315A
04:00 PM - 07:30 PM Abstract 066 - A New Motor Neuron Disease Maps to Chromosome 4ptel-4p16.1
04:00 PM - 07:30 PM Abstract 067 - Heterozygous Rare Variants Associated with Gaucher Disease Confer Robust Susceptibility to Parkinson Disease
04:00 PM - 07:30 PM Abstract 068 - A Comprehensive Molecular Genetic Characterisation of Dystrophinopathies
04:00 PM - 07:30 PM Abstract 069 - Intravenous Lidocaine Infusion and Oral Mexelitine Therapy for Dystonia in Corticobasal Degeneration
04:00 PM - 07:30 PM Abstract 070 - Botulinum Toxin in the Treatment of Spastic Foot Drop in Multiple Sclerosis: An Analysis of the Effects on Gait, Fatigue and Quality of Life
04:00 PM - 07:30 PM Abstract 071 - Kinematic Analysis of Upper Limb Movements in Multiple Sclerosis Patients Pre- and Post-CIMT
04:00 PM - 07:30 PM Abstract 072 - Somatic Sensory Responses in Motor Cortex Neurons in a Person with Tetraplegia
04:00 PM - 07:30 PM Abstract 073 - Effectiveness of an Individualized Program, Based on Proprioceptive Neuromuscular Facilitation Techniques in a Patient with Inclusion Body Myositis Associated with HIV Infection: Description and Preliminary Results
04:00 PM - 07:30 PM Abstract 074 - Lower Scores in Attention/Executive Functioning Is Associated with Probable REM Sleep Behavior Disorder among Cognitively Normal Elderly Subjects: The Mayo Clinic Study of Aging
04:00 PM - 07:30 PM Abstract 075 - Early Diagnosis of Alzheimer's Disease with CSF Biomarkers Is Improved with Longitudinal MRI Measurements of Brain Atrophy
04:00 PM - 07:30 PM Abstract 076 - Vitamin E Use Is Associated with Improved Survival in an AD Cohort
04:00 PM - 07:30 PM Abstract 077 - What Do You Mean by Semantic Dementia?
04:00 PM - 07:30 PM Abstract 078 - Treatment Practices of Mild Cognitive Impairment in California Alzheimer's Disease Centers
04:00 PM - 07:30 PM Abstract 079 - Inter-Rater Reliability between Expert and Nonexpert Physicians in the Diagnosis of Amnesic MCI in the Community Setting
04:00 PM - 07:30 PM Abstract 080 - Polysomnographic Evidence of Sleep Fragmentation and Poor Sleep Efficiency in Dementia with Lewy Bodies
04:00 PM - 07:30 PM Abstract 081 - Autosomal Dominant Subcortical Gliosis Presenting as Frontotemporal Dementia: Clinical and Histopathology Descriptions
04:00 PM - 07:30 PM Abstract 082 - Clinical Implications of Abnormal TDP-43 Immunoreactivity in Pathologically Confirmed Alzheimer's Disease
04:00 PM - 07:30 PM Abstract 083 - Change in Parkinsonian Signs and Incident Falls
04:00 PM - 07:30 PM Abstract 084 - Overlapping Features of Dementia with Lewy Bodies and Frontotemporal Dementia Associated with Pathological Frontotemporal Lobar Degeneration with Motor Neuron Disease
04:00 PM - 07:30 PM Abstract 085 - Psychotic Phenomenology of DLB: An Updated Retrospective Sample of 79 Patients
04:00 PM - 07:30 PM Abstract 086 - Daytime Hypersomnolence on the Multiple Sleep Latency Test in Patients with Dementia with Lewy Bodies
04:00 PM - 07:30 PM Abstract 087 - Incidence of Vitamin B12 Deficiency in a Cohort of Patients with Pre-Existing Alzheimer Disease
04:00 PM - 07:30 PM Abstract 088 - Oculomotor Function in Frontotemporal Lobar Degeneration and Alzheimer's Disease
04:00 PM - 07:30 PM Abstract 089 - The Differential of sCJD
04:00 PM - 07:30 PM Abstract 090 - Cognitive Profile in Dementia with Lewy Bodies and Alzheimer's Disease
04:00 PM - 07:30 PM Abstract 091 - Prognosis of Chinese Patients with Stroke Associated with Small Vessel Disease (SSVD) - A Three-Year Follow-Up Study
04:00 PM - 07:30 PM Abstract 092 - Parkinsonism Is Associated with Probable REM Sleep Behavior Disorder in Cognitively Normal Elderly Subjects: The Mayo Clinic Study of Aging
04:00 PM - 07:30 PM Abstract 093 - Fragile X Dementia/Parkinson's Syndrome (FXDP)
04:00 PM - 07:30 PM Abstract 094 - Difference of Anterior and Posterior Cerebral Vasomotor Reactivity in Migraineurs with or without Aura
04:00 PM - 07:30 PM Abstract 095 - Utility of Pulsatility Index in Idiopathic Intracranial Hypertension
04:00 PM - 07:30 PM Abstract 096 - A Survey of General Headache Disorder Knowledge among Military Beneficiaries at Walter Reed Army Medical Center (WRAMC)
04:00 PM - 07:30 PM Abstract 097 - The Application of Transcranial Magnetic Stimulation in Facial Neuralgia: A Peripheral Approach
04:00 PM - 07:30 PM Abstract 098 - Temporal Summation in Pain Perception Is Primarily Modulated in the Posterior Part of the Anterior Cingulate Cortex
04:00 PM - 07:30 PM Abstract 099 - Sleep Complaints, Emotional Disorders, and Serotonin Effects in Adolescent Migraine
04:00 PM - 07:30 PM Abstract 100 - Comparative Epidemiology and Clinical Characteristics of Migraine and Chronic Daily Headaches in an Urban Nigerian Community
04:00 PM - 07:30 PM Abstract 101 - Isolated Headache Mimicking Migraine as Sole Feature of a Massive Cerebral Venous Thrombosis
04:00 PM - 07:30 PM Abstract 102 - The Acute Treatment of Episodic and Chronic Migraine in the United States
04:00 PM - 07:30 PM Abstract 103 - Migraine and Co-Morbid PTSD: Headache Characteristics and Treatment Outcomes at a Military Neurology Clinic
04:00 PM - 07:30 PM Abstract 104 - Transfusion of Blood Products and Clinical Outcome in Patients with Intracerebral Hemorrhage
04:00 PM - 07:30 PM Abstract 105 - A Multicenter Comparison of Outcomes with Nicardipine and Nitroprusside for Treatment of Acute Hypertension in Patients with Intracerebral Hemorrhage: The 'AMUST' Study
04:00 PM - 07:30 PM Abstract 106 - Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors and Influence on Clinical Outcome. Results of a Prospective Multicenter Study
04:00 PM - 07:30 PM Abstract 107 - Brain Volume Increases after Intracerebral Hemorrhage without Clinical Worsening
04:00 PM - 07:30 PM Abstract 108 - Hemorrhage in Posterior Reversible Encephalopathy Syndrome (PRES): Imaging and Clinical Features
04:00 PM - 07:30 PM Abstract 109 - Frequent Anti-Hypertensive Treatment during Revascularization Therapy Is Associated with Intracerebral Hemorrhage in the First 24 Hours
04:00 PM - 07:30 PM Abstract 110 - Outcome of Patients with Subarachnoid Hemorrhage Presenting with a Hunt-Hess Score of IV, and Endovascular Treatment
04:00 PM - 07:30 PM Abstract 111 - Intracerebral Hemorrhage with Intraventricular Extension Is a Predictor of Autonomic Instability
04:00 PM - 07:30 PM Abstract 112 - Thalamic Hemorrhage: Analyses on Causes and Short-Term Outcome
04:00 PM - 07:30 PM Abstract 113 - Estradiol for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
04:00 PM - 07:30 PM Abstract 114 - Prodromal Headache among Patients with Acute Ischemic Stroke
04:00 PM - 07:30 PM Abstract 115 - Family Physician's Awareness and Approach Regarding Stroke in Pakistan
04:00 PM - 07:30 PM Abstract 116 - Reactive Microglia in the Hypothalamus after Glutamate Administration
04:00 PM - 07:30 PM Abstract 117 - Intraoperative EEG during Carotid Stenting: A Prospective Evaluation of the High Risk Patients
04:00 PM - 07:30 PM Abstract 118 - Paroxysmal Atrial Fibrillation in Cryptogenic Stroke
04:00 PM - 07:30 PM Abstract 119 - Neuropsychological Findings in Intracerebral Hemorrhage
04:00 PM - 07:30 PM Abstract 120 - Detection of Paroxysmal Atrial Fibrillation in Patients after Cerebral Ischemic Events with Transtelephonic ECG Monitoring
04:00 PM - 07:30 PM Abstract 121 - Midline Shift Following Ventriculostomy: A Fatal Complication
04:00 PM - 07:30 PM Abstract 122 - Clinical Predictors of Malignant Middle Cerebral Artery Syndrome: A Retrospective Chart Analysis
04:00 PM - 07:30 PM Abstract 123 - Predictors of Hemorrhagic Infarct in Superior Sagittal Sinus Thrombosis
04:00 PM - 07:30 PM Abstract 124 - 111Indium Labeled Platelets in a Preclinical Carotid Injury Model Using Cutting Balloons
04:00 PM - 07:30 PM Abstract 125 - Vertebral Artery Ostial Stenting as a Safe and Effective Modality for Symptomatic Patients Unresponsive to Medical Therapy
04:00 PM - 07:30 PM Abstract 126 - Thrombotic Cerebrovascular Disease Related to Hormone Therapy in Women
04:00 PM - 07:30 PM Abstract 127 - Evaluation of Circle of Willis Variations with 64-Slice CT Angiography
04:00 PM - 07:30 PM Abstract 128 - High Incidence of Intracranial Atherosclerosis in Patients with Acute Ischemic Stroke
04:00 PM - 07:30 PM Abstract 129 - Diabetes Is Associated with Intracranial Large Artery Disease among Ethnic Chinese but Not Ethnic South Asian Ischemic Stroke Patients
04:00 PM - 07:30 PM Abstract 130 - Expanding Applications of Intracranial Wingspan Stent in Acute Cerebral Ischemia
04:00 PM - 07:30 PM Abstract 131 - Ipsilateral Axial Lateropulsion as an Initial Symptom of Lateral Medullary Infarction: A Case Report
04:00 PM - 07:30 PM Abstract 132 - Effect of Cigarette Smoking on Outcomes of Acute Ischemic Stroke Patients Treated with Intra-Arterial Thrombolysis: Is There Any Paradox in the Brain?
04:00 PM - 07:30 PM Abstract 133 - Correlation between the Ultrasonographic and Perioperative Macroscopic Finding in the Differentiation of Acute Internal Carotid Artery Occlusion
04:00 PM - 07:30 PM Abstract 134 - Cognitive Impairment in Women Newly Diagnosed with Breast Cancer
04:00 PM - 07:30 PM Abstract 135 - Cognitive Decline in Patients Receiving Different Modalities of Cranial Irradiation
04:00 PM - 07:30 PM Abstract 136 - Intracranial Dural Metastases
04:00 PM - 07:30 PM Abstract 137 - Myelomatous Meningitis
04:00 PM - 07:30 PM Abstract 138 - A Phase I Study Using Intralumbar Injection of I-131 Sodium Iodide To Treat Leptomeningeal Metastases (LM)
04:00 PM - 07:30 PM Abstract 139 - Squamous Cell Skin Cancer Causing Leptomeningeal Carcinomatosis
04:00 PM - 07:30 PM Abstract 140 - Multifocal Deficits Due to Tumoral Meningoradiculitis in Chronic Lymphocytic Leukemia
04:00 PM - 07:30 PM Abstract 141 - Early Relapses in Primary CNS Lymphoma after Response to Polychemotherapy without Intraventricular Treatment: Results of a Phase II Study
04:00 PM - 07:30 PM Abstract 142 - Early Clinical and Radiological Description of Primary Central Nervous System Lymphoma
04:00 PM - 07:30 PM Abstract 143 - Primary Central Nervous System Lymphoma in Immunocompetent Patients: Experience in a Neurological Centre in Argentina
04:00 PM - 07:30 PM Abstract 144 - The Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome
04:00 PM - 07:30 PM Abstract 145 - Milnacipran for the Treatment of Fibromyalgia Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
04:00 PM - 07:30 PM Abstract 146 - Milnacipran Treatment for Fibromyalgia Syndrome: One-Year Durability of Response
04:00 PM - 07:30 PM Abstract 147 - Spinal Cord Stimulation Versus Conventional Medical Management: Preliminary Long-Term Results from the PROCESS Study: A Multi-Center Randomized Controlled Trial Investigating the Treatment of Patients with Failed Back Surgery Syndrome
04:00 PM - 07:30 PM Abstract 148 - Diagnosing Parkinson's Disease: The Impact on Patients and Their Caregivers
04:00 PM - 07:30 PM Abstract 149 - One 60-Minute Application of a High-Concetration Capsaicin Patch (NGX-4010) Significantly Reduced Pain for up to 3 Months in Patients with Postherpetic Neuralgia: Results from a Randomized, Double-Blind, Controlled Phase 3 Study
04:00 PM - 07:30 PM Abstract 150 - Lacosamide in Patients with Painful Diabetic Neuropathy: A Summary of Adverse Events in Four Double-Blind Randomized Clinical Trials
04:00 PM - 07:30 PM Abstract 151 - Possible Involvement of Nitrergic Neurotransmission in Duloxetine Mediated Anti-Nociception in Mouse Model of Diabetic Neuropathic Pain
04:00 PM - 07:30 PM Abstract 152 - Botulinum Toxin A for Treatment of Chronic Refractory Neck Pain
04:00 PM - 07:30 PM Abstract 153 - A Randomized, Controlled, Open-Label Investigation of the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Subjects
04:00 PM - 07:30 PM Abstract 154 - Efficacy and Tolerability of Tapentadol for Relief of Moderate-to-Severe Chronic Pain Due to Osteoarthritis of the Knee
04:00 PM - 07:30 PM Abstract 155 - Duloxetine in the Treatment of Intractable Trigeminal Neuralgia
04:00 PM - 07:30 PM Abstract 156 - Efficacy of Tapentadol, a Novel Centrally Acting Analgesic with a Dual Mode of Action, in Animal Models of Chronic Neuropathic Pain
04:00 PM - 07:30 PM Abstract 157 - Efficacy of Tapentadol, a Novel Centrally Acting Analgesic with a Dual Mode of Action, in Animal Models of Visceral Pain
04:00 PM - 07:30 PM Abstract 158 - Evaluation of Lacosamide in Diabetic Neuropathic Pain Trials
04:00 PM - 07:30 PM Abstract 159 - Correlation of Epidermal Nerve Fiber Density (ENFD) Changes and Anti-Nociceptive Effect Following Simultaneous Exposure to Static and Time-Varying Electromagnetic Fields (PEMF) in Painful Diabetic Neuropathy (DPN)
04:00 PM - 07:30 PM Abstract 160 - Modeling the Role of Small Fiber Neuropathy on Wound Healing
04:00 PM - 07:30 PM Abstract 161 - Diagnosing Diabetic Small Fiber Neuropathy Using the Skin Blister Method
04:00 PM - 07:30 PM Abstract 162 - Correlates of Painful Neuropathic Symptoms in HIV Sensory Neuropathy
04:00 PM - 07:30 PM Abstract 163 - Clinical and Electrophysiologic Findings in Cryptogenic Sensorimotor Polyneuropathy Compared to Diabetic Polyneuropathy and Normal Controls
04:00 PM - 07:30 PM Abstract 164 - Weakness, Pain and Ambulation Difficulty Are Potential Risk Factors for Motor Vehicle Accidents in Patients with Neuropathy
04:00 PM - 07:30 PM Abstract 165 - Effect of Pregabalin on Dynamic Allodynia in Patients with Postherpetic Neuralgia (PHN): Results from a Double-Blind, Randomized, Controlled Trial (RCT)
04:00 PM - 07:30 PM Abstract 166 - Pregabalin and Central Sensitization in Chronic Pain Syndromes: Evidence Supporting a Common Pharmacologic Effect
04:00 PM - 07:30 PM Abstract 167 - Duloxetine in the Management of Chronic Pain
04:00 PM - 07:30 PM Abstract 168 - Botulinum Toxin A Induces Long Term Analgesic Effects on Neuropathic Pain: A Randomized Placebo Controlled Study
04:00 PM - 07:30 PM Abstract 169 - Intraoperative Monitoring of Peripheral Nerve Function
04:00 PM - 07:30 PM Abstract 170 - Effects of Lipopolysaccharide, EDTA, and Glucose, on Muscle Cell Viability in Culture Relevant to the Conditions of Sepsis, Hypocalcemia, and Hyperglycemia in the Development of Critical Illness Myopathy
04:00 PM - 07:30 PM Abstract 171 - Elevated B6 Levels and Peripheral Neuropathies
04:00 PM - 07:30 PM Abstract 172 - Does the Mode of Minocycline Delivery Determine the Recovery from Partial Nerve Injury?
04:00 PM - 07:30 PM Abstract 173 - Is Hyperhomocysteinemia (HHcy) an Independent Risk Factor for Peripheral Neuropathy?
04:00 PM - 07:30 PM Abstract 174 - Life-Table Analysis of Peripheral Neuropathy after Bariatric Surgery: A Retrospective Cohort Study of Patients Who Had Surgery Performed at One Institute
04:00 PM - 07:30 PM Abstract 175 - Peripheral Nerve Injuries (PNIs) Following Total Hip (THR) and Knee Replacement (TKR) Surgeries: Risk Factors and the Hospital for Special Surgery (HSS) Experience
04:00 PM - 07:30 PM Abstract 176 - Radiation Induced Brachial Plexopathy Following Locoregional Irradiation for Breast Cancer: Clinical and Electrophysiologic Findings
04:00 PM - 07:30 PM Abstract 177 - Post-Irradiation Lumbosacral Radiculopathy with Multiple Spinal Root Cavernomas Mimicking Carcinomatous Meningitis
04:00 PM - 07:30 PM Abstract 178 - Evaluation of Peripheral Nerve Involvement in Patients with CADASIL Using Nerve Conduction Study
04:00 PM - 07:30 PM Abstract 179 - Efficacy and Safety of Ralfinamide in a 8-Week, Randomised, Double-Blind, Placebo Controlled, International Trial in Patients with Neuropathic Pain (NP). Ralfinamide 001 Study Group
04:00 PM - 07:30 PM Abstract 180 - Burden of Illness in Indian Patients with Neuropathic Pain: Results of a Cross-Sectional Study
04:00 PM - 07:30 PM Abstract 181 - Acquired Severe Polyneuropathy in Non-Intubated Patients of Intensive Care Unit (ICU): Is This a Subtype of Critical Illness Polyneuropathy (CIP)?
04:00 PM - 07:30 PM Abstract 182 - Relevance of F Wave Abnormality in Focal Neuropathies
04:00 PM - 07:30 PM Abstract 183 - Normal Ulnar Sensory Nerve Conduction Studies in Electrophysiologically Proven Ulnar Neuropathy at the Elbow May Not Be so Normal
04:00 PM - 07:30 PM Abstract 184 - Clinical, Electrophysiological and Pathological Studies in Late Infantile Metachromatic Leukodystrophy
04:00 PM - 07:30 PM Abstract 185 - Which Transcarpal Conduction Technique Is the Best for Electrodiagnosis of Carpal Tunnel Syndrome?
04:00 PM - 07:30 PM Abstract 186 - Repetitive Components of Compound Motor Action Potential in DM1 Patients
04:00 PM - 07:30 PM Abstract 187 - Post-Exercise Exhaustion Is Observed at the Different Time after Exercise in MG
04:00 PM - 07:30 PM Abstract 188 - Differential Orbicularis Oculi Involvement in Neuromuscular Junction Dysfunction
04:00 PM - 07:30 PM Abstract 189 - QST in Neuropathic Pain: Retrospective Study in 108 Patients
04:00 PM - 07:30 PM Abstract 190 - The Generator of Spontaneous Muscle Activity Following Upper Motor Neuron Injury Is Distal
04:00 PM - 07:30 PM Abstract 191 - Electrical Impedance Myography: A Potential Alternative to Needle Electrode Examination in the Evaluation of Carpal Tunnel Syndrome
04:00 PM - 07:30 PM Abstract 192 - Clinical and Electrophysiologic Findings in Patients with Radiating Neck Pain: When Is the EMG Helpful?
06:00 PM - 07:30 PM Break
Faculty Disclosures
Leigh R. Hochberg, MD, PhD, FAAN The institution of Dr. Hochberg has received research support from The MGH Translational Research Center has a clinical research support agreement (CRSA) with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron, and Reach Neuro, for which LRH provides consultative input. LRH is a non-compensated member of the Board of Directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham (MGB) is convening the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to MGB, including those received to date from Paradromics, Synchron, Precision Neuro, Neuralink, and Blackrock Neurotech, support the iBCI-CC, for which LRH provides effort.. The institution of Dr. Hochberg has received research support from Dr. Hochberg also receives research support from the US Department of Veterans Affairs and the National Institutes of Health.. Dr. Hochberg has received intellectual property interests from a discovery or technology relating to health care.
Andres M. Villa, MD Dr. Villa has nothing to disclose.
No disclosure on file
Richard L. Skolasky, BA No disclosure on file
Daniel Woo, MD, FAAN The institution of Dr. Woo has received research support from NIH.
Joseph P. Broderick, MD, FAAN The institution of Dr. Broderick has received research support from Novo Nordisk. Dr. Broderick has received publishing royalties from a publication relating to health care.
Jonathan S. Katz, MD Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Salah G. Keyrouz, MD No disclosure on file
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Heidi L. Roth, MD, FAAN No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Glenn E. Smith, MD, PhD No disclosure on file
Yousef Mohammad, MD No disclosure on file
Luc Defebvre No disclosure on file
Christian Denier No disclosure on file
Marc Chamberlain, MD No disclosure on file
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Philippe Corcia, MD No disclosure on file
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
James W. Schmidley, MD No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
John J. Millichap, MD, FAAN Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis. Dr. Millichap has received publishing royalties from a publication relating to health care.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Sa-Yoon Kang, MD No disclosure on file
Jean-Christophe Antoine, MD No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Jan Mares, MD Dr. Mares has nothing to disclose.
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Sandrine Deltour, MD No disclosure on file
Edward J. Kasarskis, MD, PhD, FAAN The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to AAN interests or activities.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Diana Richardson, MD No disclosure on file
Didier Bouhassira, MD, PhD No disclosure on file
Marc Sanson No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
S H. Subramony, MBBS, FAAN Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex.
Eva Milano No disclosure on file
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Isabella L. Simone No disclosure on file
Stella Lee No disclosure on file
Niall Pender, PhD No disclosure on file
Andrew Tarulli, MD No disclosure on file
Stamatis A. Zeris No disclosure on file
Sookyong Koh, MD, PhD No disclosure on file
Jung-Hwan Oh, MD No disclosure on file
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Uwe S. Schlegel No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Chin-San Liu No disclosure on file
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Hendrik Pels No disclosure on file
Sudhakar Tummala, MD, FAAN Dr. Tummala has nothing to disclose.
John Shoffner IV, MD No disclosure on file
Heinz Reichmann, MD, FAAN Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Morris D. Groves, Jr., MD No disclosure on file
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Robert J. Ivnik, PhD No disclosure on file
Anita L. Belman, MD, FAAN No disclosure on file
Olivia S. Kim Mcmanus, MD Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kim Mcmanus has received research support from California Institute for Regenerative Medicine. The institution of Dr. Kim Mcmanus has received research support from National Institutes of Health/NCATS.
G. F. Wooten, MD No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Alain Destee, MD, PhD No disclosure on file
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Akram Shhadeh, MD, MBA No disclosure on file
Ammar Al Kawi, MD, FAAN Dr. Al Kawi has nothing to disclose.
Anamarli Nucci No disclosure on file
Annika Berger, MD No disclosure on file
Edward T. Neely, MD No disclosure on file
JiHoon Kang, MD, PhD No disclosure on file
Sophie Pittion Sophie Pittion has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Vladimir Skljarevski, MD No disclosure on file
Siong-Chi Lin, MD No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
William Camu, MD No disclosure on file
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Antoine Gueguen, MD An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Ewa E. Chelmicka-Schorr, MD No disclosure on file
Amer Alshekhlee, MD No disclosure on file
Martin A. Nogues No disclosure on file
Mena Scavina, DO The institution of Dr. Scavina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Scavina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Parent Project Muscular Dystrophy.
Marcelo E. Bigal, MD, PhD No disclosure on file
Marcos R. De Freitas, MD, PhD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Daniel S. Newman, MD Dr. Newman has nothing to disclose.
Garth Nicholson, PhD No disclosure on file
Rodney D. Bell, MD Dr. Bell has received publishing royalties from a publication relating to health care.
Vinaykumar Puduvalli, MD Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Milind J. Kothari, DO, FAAN No disclosure on file
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Tammy Tsuchida, MD, PhD The institution of Dr. Tsuchida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals Inc. The institution of Dr. Tsuchida has received research support from Xenon Pharmaceuticals Inc.
Susan Woolley Levine, PhD No disclosure on file
Sarah Davis No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Teresa J. Buracchio, MD No disclosure on file
Ulrich Bogdahn, MD No disclosure on file
Lauren B. Krupp, MD, FAAN Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Antonino Pavone No disclosure on file
Mark Obermann, MD, FAAN No disclosure on file
Catherine Griffin, MD No disclosure on file
Annie Verschueren No disclosure on file
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Philippe Convers No disclosure on file
Cynthia F. Barton No disclosure on file
Kenneth Silver, MD No disclosure on file
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Biju Thomas No disclosure on file
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Jay C. Erickson, MD No disclosure on file
Nathalie Guy Renouil, MD No disclosure on file
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Chin-Sang Chung, MD, PhD No disclosure on file
Jerry A. Hall No disclosure on file
Pasquale Montagna, MD No disclosure on file
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Moris J. Danon, MD, FAAN No disclosure on file
Stephen N. Scelsa, MD No disclosure on file
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Nicholas S. Abend, MD, FAAN Dr. Abend has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Abend has received research support from NIH. The institution of Dr. Abend has received research support from PCORI. Dr. Abend has received publishing royalties from a publication relating to health care.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Kachikwu O. Illoh, MD No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Joy B. Parrish An immediate family member of Ms. Parrish has received personal compensation for serving as an employee of DPK Technology. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National football league. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Hockey League.
Teena Shetty, MD, FAAN Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
James P. Wymer, MD, PhD, FAAN No disclosure on file
Lakshmi Nayak, MD Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curis. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Nayak has received publishing royalties from a publication relating to health care.
Misha-Miroslav Backonja, MD Dr. Backonja has nothing to disclose.
Rema Raman, PhD No disclosure on file
Agustin Legido, MD, PhD, MBA No disclosure on file
Khe Hoang-Xuan, MD No disclosure on file
Igor Nestrasil No disclosure on file
Angelo Ghezzi, MD No disclosure on file
Nizar Chahin, MD Dr. Chahin has nothing to disclose.
Thomas Tomsick No disclosure on file
David Devos The institution of Mr. Devos has received research support from Alterity.
Carissa Pineda, MD Dr. Pineda has nothing to disclose.
Lauren C. Hyams, PhD No disclosure on file
Hemalatha Narra, MD No disclosure on file
Zoe Arvanitakis, MD, MS, FAAN Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governemental entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Brett J. Theeler, MD, FAAN Dr. Theeler has nothing to disclose.
Rosebud O. Roberts, MD No disclosure on file
Charles A. Conrad, MD No disclosure on file
Julie Phukan, MB, BCh, MRCPI No disclosure on file
Syed A. Hosain, MD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
Reena M. Nanjireddy, MD No disclosure on file
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Cecile Maugras No disclosure on file
Steve DeRoos, MD Dr. DeRoos has nothing to disclose.
Amy S. Chappell, MD, FAAN Dr. Chappell has received personal compensation for serving as an employee of Eliem Therapeutics. Dr. Chappell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pinteon. Dr. Chappell has received stock or an ownership interest from Eliem.
Mohammed S. Sanjak, PhD No disclosure on file
Olga A. Prokhorenko, MD No disclosure on file
Carlos A. Luciano, MD, FAAN Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Vazquez-Irizarry Law Office. The institution of Dr. Luciano has received research support from National Institutes of Health. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Agostino Baruzzi, MD No disclosure on file
Michael Glantz, MD, FAAN No disclosure on file
Marie Fleury No disclosure on file
Joshua Mekler, MD No disclosure on file
John Stephenson No disclosure on file
Chiara La Morgia, MD Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
A. D. Rothner, MD No disclosure on file
Christine I. Dali, MD Dr. Dali has received personal compensation for serving as an employee of Orphazyme A/S .
Joseph Nguyen, DO Dr. Nguyen has nothing to disclose.
Anthony T. Yachnis, MD No disclosure on file
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has received publishing royalties from a publication relating to health care.
Michael J. Boivin No disclosure on file
Chethan P. Venkatasubba Rao, MD Dr. Venkatasubba Rao has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Maestro Inc.
David N. Herrmann, MD, FAAN Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Jean-Yves Delattre, MD No disclosure on file
Vladimiro Sinay, MD No disclosure on file
Silvia Tenembaum, MD Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. .
Kevin R. Scott, MD, FAAN No disclosure on file
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Marcello Romano, MD No disclosure on file
Francis I. Ojini, MD No disclosure on file
Matthew J. Baker, MD No disclosure on file
Joseph C. Masdeu, MD, PhD, FAAN Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Sushant P. Kale, MD No disclosure on file
Ann Pakalnis, MD No disclosure on file
Wei Tang, MD, PhD No disclosure on file
Caroline Moreau, MD No disclosure on file
Pierre Lozeron No disclosure on file
Russell H. Swerdlow, MD No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
Gal Ifergane, MD Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceretrieve. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Ifergane has received research support from Teva.
Anjali N. Shah, MD No disclosure on file
Kimbra L. Kenney, MD, FAAN Dr. Kenney has nothing to disclose.
Ismael R. Ali, MD No disclosure on file
David Skoloudik, MD, PhD No disclosure on file
Itzik Wirguin, MD No disclosure on file
Michael H. Kohrman, MD No disclosure on file
Rocco Liguori, MD Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HEALTHWARE GROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION PHARMA ITALY s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME CORPORATION . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ECM NETWORK s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTS s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AIM EDUCATION s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MAYA IDEE SUD s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ISTITUTO SUPERIORE DI SANITA' . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for QbGROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SYMPOSIUM s.r.l. . Dr. Liguori has received publishing royalties from a publication relating to health care.
William R. Kennedy, MD, FAAN No disclosure on file
Christopher H. Gibbons, MD, FAAN Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Susanne Barth, MD No disclosure on file
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Bong-Su Kang, MD No disclosure on file
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Ferah Kizilay, MD No disclosure on file
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Kipp L. Chillag, DO Dr. Chillag has nothing to disclose.
Andrea Weinstein No disclosure on file
Claudine Sinsioco, MD No disclosure on file
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Omar Garcia No disclosure on file
Adam L. Boxer, MD, PhD An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Michael Katsnelson, MD No disclosure on file
Diana Miller, MD No disclosure on file
Dimitri Psimaras, MD No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Antonio Federico, MD, Prof No disclosure on file
Zulfiqar Hussain, MD No disclosure on file
Yvonne Rollins, MD No disclosure on file
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Maja Tippmann-Peikert, MD Dr. Tippmann-Peikert has nothing to disclose.
Lauren E. Abrey, MD No disclosure on file
Joanna Hellmuth, MD Dr. Hellmuth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McAngus Goudelock & Courie law firm.
Carlayne E. Jackson, MD, FAAN Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Daniel J. Licht, MD No disclosure on file
Michael I. Weintraub, MD, FACP, PC, FAAN Dr. Weintraub has nothing to disclose.
Derya Kaya No disclosure on file
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
A. Gordon Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Ignacio Valencia, MD No disclosure on file
Francois Ducray No disclosure on file
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Divya S. Khurana, MD No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
S. Charles Bean, MD No disclosure on file
Gary Hunter, MD No disclosure on file
Howard W. Sander, MD, FAAN Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Ravi Anand No disclosure on file
Jun Goto, MD, PhD No disclosure on file
Valory Pavlik, PhD The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Alisa L. Clark, MSN, CRNP No disclosure on file
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Allyson Zazulia An immediate family member of Dr. Zazulia has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care Society.
Christopher H. Hawkes, MD, Bsc, FRCP, FAAN Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Susan D. Rountree, MD No disclosure on file
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Christiane Reitz, MD, PhD No disclosure on file
Martin Bares, PhD No disclosure on file
Francesca Gilli No disclosure on file
William J. Powers, MD, FAAN Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities.
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Stefano M. Rossetti, MD No disclosure on file
Tapas K. Banerjee, MD, MBBS, FRCP, FAAN Dr. Banerjee has nothing to disclose.
Anita T. Wu, MD No disclosure on file
Joseph J. Melvin, DO Dr. Melvin has received personal compensation in the range of $100,000-$499,999 for serving as a Physican with Tower health.
Omar Dabbagh, MD, FAAN No disclosure on file
Christopher Voll, PhD, FRCP(c) No disclosure on file
Tatyana Yuzbashyan, MD No disclosure on file
Michael N. Diringer, MD No disclosure on file
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Fuki M. Hisama, MD, FAAN An immediate family member of Dr. Hisama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. The institution of Dr. Hisama has received research support from UW Brotman Baty Precision Medicine Institute. The institution of Dr. Hisama has received research support from NIH/NHGRI.
Walter G. Bradley, DM, FRCP, FAAN No disclosure on file
Pietro Tonali, MD No disclosure on file
Charles Torres-Chae No disclosure on file
Mingxin Tang, PhD No disclosure on file
Meng C. Wong, MBBS, MMed, FAAN No disclosure on file
Jun Mitsui No disclosure on file
Marcella Masciullo No disclosure on file
Gabriella Silvestri, MD No disclosure on file
Mauro Lo Monaco, MD No disclosure on file
Lisa Mosconi No disclosure on file
Kirk C. Wilhelmsen, MD, PhD No disclosure on file
Eric Avila No disclosure on file
Vincent C. Mok, MD, MBBS No disclosure on file
Paul Valdmanis No disclosure on file
Nicolas Gaillard No disclosure on file
Ioanna Panoutsopoulou, MD No disclosure on file
Bruno J. Giordani, PhD No disclosure on file
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Paolo Marchettini, MD No disclosure on file
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Nobutaka Hattori, MD, PhD, FANA Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PARKINSON Laboratories Co., Ltd. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEIJIN PHARMA LIMITED.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sumitomo Dainippon Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie GK. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Holdings Co.,Ltd.. Prof. Hattori has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd. . Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sumitomo Dainippon Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma K.K.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DAIICHI SANKYO Co., Ltd.. Prof. Hattori has received stock or an ownership interest from PARKINSON Laboratories Co., Ltd. The institution of Prof. Hattori has received research support from Japan Society for the Promotion of Science (JSPS). The institution of Prof. Hattori has received research support from Japan Agency for Medical Research and Development (AMED). The institution of Prof. Hattori has received research support from Japan Science and Technology Agency, Health Labour Sciences Research Grant. The institution of Prof. Hattori has received research support from Japan Science and Technology Agency (JST). The institution of Prof. Hattori has received research support from Kyowa Kirin Co.,Ltd.. The institution of Prof. Hattori has received research support from Medtronic, Inc.. The institution of Prof. Hattori has received research support from Boston Scientific Corporation. The institution of Prof. Hattori has received research support from TEIJIN PHARMA LIMITED.. The institution of Prof. Hattori has received research support from AbbVie GK. The institution of Prof. Hattori has received research support from FP Pharmaceutical Corporation. The institution of Prof. Hattori has received research support from Dai-Nippon Sumitomo Pharma Co.,Ltd. The institution of Prof. Hattori has received research support from Nihon Medi-physics Co.,Ltd.,. The institution of Prof. Hattori has received research support from Eisai Co.,Ltd. . The institution of Prof. Hattori has received research support from Kirin Holdings Company, Limited. The institution of Prof. Hattori has received research support from Mitsubishi UFJ Trust and Banking Corporation. The institution of Prof. Hattori has received research support from GLORY LTD.. The institution of Prof. Hattori has received research support from Nippon Life Insurance Company. The institution of Prof. Hattori has received research support from Otsuka Pharmaceutical, Co.,Ltd. The institution of Prof. Hattori has received research support from AbbVie GK,. The institution of Prof. Hattori has received research support from Meiji Seika Pharma Co., Ltd.. The institution of Prof. Hattori has received research support from Ono Pharmaceutical Co., Ltd.. The institution of Prof. Hattori has received research support from FUJIFILM Wako Pure Chemical Corporation. The institution of Prof. Hattori has received research support from Sunwels,Inc.. The institution of Prof. Hattori has received research support from OHARA Pharmaceutical Co.,Ltd.. The institution of Prof. Hattori has received research support from PARKINSON Laboratories Co., Ltd.. The institution of Prof. Hattori has received research support from Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Team Leader with RIKEN Center for Brain Science. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Program officer with AMED: Japan Agency for Medical Research and Development.
Mandar S. Jog, MD, FAAN Dr. Jog has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Jog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ipsen. Dr. Jog has stock in MDDT .
Anna Modoni No disclosure on file
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Alex Hlubocky, MD No disclosure on file
Gonzalo Revuelta, DO The institution of Dr. Revuelta has received research support from NIH.
Abdul Malik, MD, FAAN No disclosure on file
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Hebah Hefzy, MD No disclosure on file
David Lacomis, MD, FAAN Dr. Lacomis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. The institution of Dr. Lacomis has received research support from Mitsubishi Tanabe. The institution of Dr. Lacomis has received research support from NIH. Dr. Lacomis has received publishing royalties from a publication relating to health care.
Bhojo Khealani, MD No disclosure on file
Valeria Caso, MD, PhD Dr. Caso has nothing to disclose.
Burkhard Gustorff, MD No disclosure on file
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Wen Y. H. Wu-Chen, MD, FAAN No disclosure on file
Miho Murata No disclosure on file
Guerry M. Peavy, PhD Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH.
Maurizio Paciaroni, MD No disclosure on file
Nitin Agarwal, MBBS Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc.
Ed Whalen Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer.
Nicole Schupf, PhD, DrPH No disclosure on file
Aissatou Haman No disclosure on file
Walter Ageno No disclosure on file
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Jennifer R. Molano, MD, FAAN Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Alexander Y. Lau, MD Dr. Lau has nothing to disclose.
Mitsutoshi Yamamoto, MD, FAAN No disclosure on file
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Luciano Merlini, Prof, FAAN No disclosure on file
Hui M. Chang, MBBS No disclosure on file
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
R. Michael Gendreau No disclosure on file
Robert G. Miller, MD The institution of Dr. Miller has received research support from Nurown.
Manikum Moodley, MD, FAAN Dr. Moodley has nothing to disclose.
Asit Tripathy, MD No disclosure on file
Krishna Mettu, MD No disclosure on file
Geertrui F. Vanhove, MD, PhD, MBA No disclosure on file
Wilson W. Bryan, MD Dr. Bryan has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Office of Tissues and Advanced Therapies with United States Food and Drug Administration (FDA).
Robert T. Leshner, MD, FAAN No disclosure on file
Joseph H. Lee, DrPH MPH BS No disclosure on file
Andrew Xavier, MD No disclosure on file
Roberto Vetrugno No disclosure on file
Juan Carlos Gil No disclosure on file
Hana Setterquist No disclosure on file
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Charles R. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Gaetano Cantalupo No disclosure on file
Erwin Chiquete, MD, PhD No disclosure on file
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Andrea Alberti No disclosure on file
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Mohammad Wasay, MBBS, FAAN Dr. Wasay has nothing to disclose.
Yong S. Lee, MD No disclosure on file
Swati Sathe, MD Dr. Sathe has received personal compensation in the range of $0-$499 for serving as a Expert opinion with FirstThought.IO.
Mme Rim Amouri, MD No disclosure on file
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Atsushi Iwata, MD No disclosure on file
Ming-hong Chang, MD Dr. Chang has nothing to disclose.
Kryshani T. Fernando, MD No disclosure on file
Charles Cho No disclosure on file
Deborah Gelinas, MD Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Faisal M. Raja, MD No disclosure on file
Ebru Barcin Mihci, MD No disclosure on file
Claude J. Desnuelle, MD No disclosure on file
Nina Barisic, MD, PhD The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving as a Consultant for roche. The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Christopher Hughes, MD, PhD No disclosure on file
Jose Maria Blasco, PhD No disclosure on file
Elliott D. Ross, MD, FAAN No disclosure on file
Ammar Shaikhouni No disclosure on file
Caterina Tonon No disclosure on file
Tatyana Kushner No disclosure on file
Marla E. Jordan-Gonzalez, MD No disclosure on file
Jeannette A. Barrett, PhD No disclosure on file
Carolin Dohle, MD Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
Michael M. Tuchman, MD, FAAN No disclosure on file
Miroslaw Brys, MD, PhD No disclosure on file
Mary R. Rensel, MD, FAAN Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Brett R. Stacey, MD No disclosure on file
Steven L. Hoover, MD No disclosure on file
Harneet Singh, MD No disclosure on file
Yuen T. So, MD, PhD, FAAN No disclosure on file
Teshamae Monteith, MD, FAAN Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a 好色先生 with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a 好色先生 with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Barry S. Russman, MD No disclosure on file
Susan De Santi, PhD No disclosure on file
Joachim M. Baehring, MD, FAAN Dr. Baehring has nothing to disclose.
Anne Y. Chan, MD No disclosure on file
Jose Luchsinger-Stuart No disclosure on file
Edwin H. Kolodny, MD, FAAN No disclosure on file
Faycal Hentati, MD No disclosure on file
Kaj Blennow Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Edith Durso-DeCruz, PhD No disclosure on file
Dan Moore, PhD No disclosure on file
Stephen A. Smith, MD No disclosure on file
Martin J. Sadowski, MD, PhD The institution of Dr. Sadowski has received research support from National Institute on Aging. The institution of Dr. Sadowski has received research support from Biogen. The institution of Dr. Sadowski has received research support from Novartis. The institution of Dr. Sadowski has received research support from Janssen Research and Development. The institution of Dr. Sadowski has received research support from Eisai. The institution of Dr. Sadowski has received research support from TauRx Therapeutics Ltd. The institution of Dr. Sadowski has received research support from Suven Life Sciences Ltd.. The institution of Dr. Sadowski has received research support from Merck Sharp & Dohme Corp.. The institution of Dr. Sadowski has received research support from Alzheimer's Disease Cooperative Study. The institution of Dr. Sadowski has received research support from Neurotrack Technologies Inc.. Dr. Sadowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Sadowski has received personal compensation in the range of $100,000-$499,999 for serving as a VA Physician with Veterans' Affairs.
Seon Hee Bu, MD No disclosure on file
Lidia Glodzik No disclosure on file
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Eric C. Munoz No disclosure on file
Wen-Ning Zhao No disclosure on file
Anil N. Rama, MD No disclosure on file
E R. Blonsky, MD No disclosure on file
Ben M. Illigens, MD Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to AAN interests or activities.
Avi A. Algom, MD No disclosure on file
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Jin-Soo Kim No disclosure on file
Gerard Besson No disclosure on file
Daniel Sanak No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Dale J. Lange, MD, FAAN No disclosure on file
Neil R. Friedman, MD, MBChB No disclosure on file
Marina Mata, MD No disclosure on file
Raymond Onders, MD No disclosure on file
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Gerald E. Grossman, MD No disclosure on file
Natalia Paoli No disclosure on file
Taeun Chang, MD No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
H. C. Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Rakesh Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Domenico Restivo, MD No disclosure on file
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Mustapha A. Danesi, MD No disclosure on file
Yashma Patel, MD No disclosure on file
Wei Liu, MD Dr. Liu has nothing to disclose.
Genevieve Langley No disclosure on file
William W. Campbell, MD, MSHA, FAAN No disclosure on file
Michal Kral No disclosure on file
Dorothee E. Chabas-Chanezon, MD, PhD No disclosure on file
Bernard Laurent No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
John P. Donoghue, PhD No disclosure on file
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Marc Fisher, MD, FAAN Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Hiroshi Mitsumoto, MD, FAAN Dr. Mitsumoto has nothing to disclose.
Giovanni Castelnovo No disclosure on file
Paolo Ghiglione, MD No disclosure on file
Majaz Moonis, MD, FAHA, FAAN Dr. Moonis has nothing to disclose.
Jeremy M. Shefner, MD, PhD, FAAN Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Sophie Crozier No disclosure on file
Yves Samson, MD No disclosure on file
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Nadine Attal, MD, PhD Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grunenthal. Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz . Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Maxona . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grunenthal . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic . Dr. Attal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolter Kluwers.
Ashok Verma, MD, FAAN Dr. Verma has nothing to disclose.
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Stephen P. Salloway, MD, MS Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.
David G. Brock, MD No disclosure on file
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Njide Okubadejo, MD, FAAN The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Patricia Melville No disclosure on file
Omar A. Khan, MD, PhD No disclosure on file
Yutaka Nishigaki, MD No disclosure on file
Pooja Khatri, MD, FAAN The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Ellen M. Mowry, MD, FAAN Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Emily Daviau No disclosure on file
Marcelo Cruzeiro, MD No disclosure on file
Anne Leger No disclosure on file
Qi Li, MD, PhD No disclosure on file
Thierry Maisonobe No disclosure on file
Mahmood S. Eisa, MD, FAAN No disclosure on file
Matteo Bigoni No disclosure on file
Christian Krarup, MD, DMSc, FRcP, FAAN Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Steven Ferris No disclosure on file
Anita Murthy No disclosure on file
Wendy Chao, DO No disclosure on file
Holger Kaube, MD No disclosure on file
Eustachio D'Errico No disclosure on file
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Filippo Martinelli Boneschi No disclosure on file
Franklin C. Wong, MD, PhD, JD, FAAN No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN Dr. Thaisetthawatkul has nothing to disclose.
James Kerns, PhD No disclosure on file
Kenneth W. Sommerville, MD, FAAN No disclosure on file
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Dennis J. Dlugos, MD Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
James Y. Garbern, MD, FAAN No disclosure on file
Dan J. Gzesh, MD, FAAN No disclosure on file
Rizma J. Bajwa, MD No disclosure on file
Scott A. Boruchow, MD No disclosure on file
Jun Zhang No disclosure on file
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
Susan E. Bennett, PT, EdD, NCS No disclosure on file
Upinder K. Dhand, MD, FAAN No disclosure on file
Laura Herbelin No disclosure on file
Gordon A. Irving, MD No disclosure on file
Chunyang Wang, MD MS No disclosure on file
Angela Nervi, MD No disclosure on file
Jeffrey Tobias, MD No disclosure on file
Nivia Hernandez-Ramos, MD No disclosure on file
Carolina Leon Jimenez, MD No disclosure on file
Yasushi Kisanuki, MD, FAAN Dr. Kisanuki has nothing to disclose.
Aaron L. Boster, MD Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Nancy McLinskey, MD No disclosure on file
Ji Man Hong No disclosure on file
John K. Fink, MD No disclosure on file
Daniel Coovert, BS No disclosure on file
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Douglas A. Dulli, MD, MS, FAAN No disclosure on file
Rosa Rademakers, PhD Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Joel Berniac No disclosure on file
Paul Higgins No disclosure on file
Chad Hoyle, MD Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Regina Troxell, MD Dr. Troxell has nothing to disclose.
Mark Luciano, MD, PhD No disclosure on file
Mark B. Bromberg, MD, PhD, FAAN Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
H. R. Brashear, MD, FAAN No disclosure on file
Mariecken V. Fowler, MD, FAAN Dr. Fowler has nothing to disclose.
Ugo Paolucci, MD No disclosure on file
Fabio M. Iwamoto, MD No disclosure on file
Marina Kennerson Marina Kennerson has nothing to disclose.
Jena Khera, MD No disclosure on file
Carol A. Manning, PhD The institution of Dr. Manning has received research support from Department of Defense.
Kimberley M. Thacker, MD No disclosure on file
Rup Tandan, MD, FRCP, FAAN Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
Julene K. Johnson No disclosure on file
Andrew Kertesz, MD, FAAN No disclosure on file
Mona M. Selim, MD No disclosure on file
Kristine M. Chapman, MD No disclosure on file
Keith Bley No disclosure on file
Amer Nouh, MD No disclosure on file
Ranjeeta Mani, MD No disclosure on file
Debabrata Ghosh, MD No disclosure on file
Christine B. Baca, MD, FAAN Dr. Baca has nothing to disclose.
Gaurav Gupta, MD No disclosure on file
Seok Kim No disclosure on file
Piernicola Marchi, MD No disclosure on file
Xi Chen, MD No disclosure on file
Edward Burton No disclosure on file
Adil Zia, MD No disclosure on file
Stu J. Glassner, DO Dr. Glassner has nothing to disclose.
Emmanuel THOMAS No disclosure on file
Sung Hyuk Heo, MD No disclosure on file
Israt Jahan, MD No disclosure on file
Marcella Souza No disclosure on file
Emmanuelle Volle No disclosure on file
Dae-Il Chang, MD No disclosure on file
Farzaneh A. Sorond, MD, PhD Dr. Sorond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Sorond has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. The institution of Dr. Sorond has received research support from NIH.
Kirk R. Daffner, MD, FAAN The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Ana C. Piccolo, MD No disclosure on file
Hung-Ming Wu No disclosure on file
Cristiane Cavalet, MD No disclosure on file
Omer F. Turan, MD Dr. Turan has nothing to disclose.
Gene Hung, MD No disclosure on file
Jindong Xu, MD No disclosure on file
Jacobo E. Mintzer Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - Global Council on Brain Health. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech (affiliate of F. Hoffmann-La Roche Ltd). Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health and Wellness Partners, LLC. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ironshore Pharmaceuticals. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Consultant for Praxis Bioresearch. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sygnature Discovery. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: NAB-It: Nabilone for Agitation Blinded Intervention Trial. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: WeCareAdvisory Study. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Technology Accelerator Company (TAC). Jacobo E. Mintzer has stock in Biopharma Connex. Jacobo E. Mintzer has stock in NeuroQuest. Jacobo E. Mintzer has stock in Recruitment Partners. The institution of Jacobo E. Mintzer has received research support from Eisai Inc.. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Clinical Trials Consortium. The institution of Jacobo E. Mintzer has received research support from Eli Lilly and Company. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Therapeutic Research Institute. The institution of Jacobo E. Mintzer has received research support from JHSPH Center for Clinical Trials. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Clinical Trials Consortium (ACTC). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Disease Cooperative Study (ADCS). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Elder Court. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Unpaid Consultant/Association Member with International Psychogeriatric Association (IPA).
Robert A. Rissman, PhD Dr. Rissman has nothing to disclose.
Rashedul Hasan, MD No disclosure on file
Mary Ganguli, MD, MPH No disclosure on file
Diana Sieciechowicz, MD No disclosure on file
Thomas Otis, MD No disclosure on file
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Serge G. Timsit No disclosure on file
Richard L. Levy, MD, FAAN No disclosure on file
Amit Chaudhari, MD, PhD No disclosure on file
Pavan Tummala, MD No disclosure on file
Selda Korkmaz, MD No disclosure on file
Maurizio Melis No disclosure on file
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Wan-Yu Huang No disclosure on file
Meryem A. Tuncer, MD Dr. Tuncer has nothing to disclose.
Daniel R. Scoles, PhD, FAAN The institution of Dr. Scoles has received research support from NIH.
Jessica E. Gomes No disclosure on file
Samir Belal, MD No disclosure on file
Alan G. Finkel, MD, FAHS, FAAN Dr. Finkel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Carolina Headache Foundation. Dr. Finkel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various.
April L. McVey, MD No disclosure on file
Yang-ki Minn, MD No disclosure on file
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
Robert W. Charlson, MD Dr. Charlson has nothing to disclose.
Naganand Sripathi, MD Dr. Sripathi has nothing to disclose.
Kari D. Moore, RN, APRN Ms. Moore has nothing to disclose.
Silvia Presas Silvia Presas has nothing to disclose.
Hong K. Song, MD No disclosure on file
Soojin Park, MD Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health.
Miguel Jacobo, MD No disclosure on file
Alberto Rodriguez Alfici, MD No disclosure on file
Thomas V. Kodankandath, MD, FAAN Dr. Kodankandath has nothing to disclose.
Seung-Han Suk, MD No disclosure on file
R. C. Gurses, MD No disclosure on file
Ela M. Akay No disclosure on file
Zeynep Caliskan No disclosure on file
Dorothee Gramatzki, MD No disclosure on file
Nouf M. Alrishi, MD Dr. Alrishi has nothing to disclose.
Larissa Vilany No disclosure on file
Carlos H. Ballario, MD No disclosure on file
Jannatul Ferdous, MD Dr. Ferdous has nothing to disclose.
Giancarlo Di Battista, MD No disclosure on file
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
Norma Deri, MD Norma Deri, MD has nothing to disclose.
Pedro G. Nofal, MD No disclosure on file
Sabahattin Saip Sabahattin Saip has nothing to disclose.
Marcos G. Burgos, MD No disclosure on file
Dimitri Renard, MD No disclosure on file
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Nicholas D. Schiff, MD Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Santiago A. Vetere, MD No disclosure on file
Gabriel D. Volman, MD No disclosure on file
Marcelo F. Rugiero, MD No disclosure on file
Abdulcemal Ozcan, MD No disclosure on file
Xavier Ayrignac Xavier Ayrignac has nothing to disclose.
Graciela Arguello De Alday, MD No disclosure on file
Lionel Naccache No disclosure on file
Valter Troni, MD No disclosure on file
Andres Barboza, MD, PhD No disclosure on file
Jae Hyeon Park, MD No disclosure on file
Rossana Neme, MD No disclosure on file
Maria Saladino No disclosure on file
Sung-Hee Hwang No disclosure on file
Sachin Agarwal, MD, MPH Dr. Agarwal has nothing to disclose.
Kavita M. Grover, MD, FAAN Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Gorazd B. Stokin, MD, PhD, FAAN Dr. Stokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Terumo. Dr. Stokin has received research support from CNS.
Sammy D. Pishanidar, MD No disclosure on file
Marie De Verdal No disclosure on file
Gaurav P. Dighe, MD No disclosure on file
Rocio Hernandez Clares, MD, PhD No disclosure on file
Margarita Moreno, MD No disclosure on file
Ramiro Linares, MD No disclosure on file
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Nadia Sotudeh, MD No disclosure on file
Hesham A. Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Tyler E. Gaston, MD Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Wallace Brownlee, MD Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Rajinder Bansal, MD No disclosure on file
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Maria Gaitan Maria Gaitan has received personal compensation in the range of $500-$4,999 for serving as a has received reimbursement for developing educational presentations and/or travel/accommodations stipends from with Merck SA, Merck-Serono Argentina, Biogen-Idec Argentina, Novartis Argentina, Roche Argentina,.
Phil Lee, PhD An immediate family member of Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Lee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Lee has received research support from NIH.
Elisabetta Ferraro, MD No disclosure on file
Maureen A. Mealy, PhD, RN No disclosure on file
Marcela Parada Marcilla, MD No disclosure on file
Fahad F. Albassam, MD No disclosure on file
Sean Selva Sean Selva has nothing to disclose.
Janina Krell-Roesch, PhD Dr. Krell-Roesch has nothing to disclose.
Gagandeep Singh, MD Dr. Singh has nothing to disclose.
Barbara Iazzolino Barbara Iazzolino has nothing to disclose.
Gunes Esendagli Gunes Esendagli has nothing to disclose.
Ahmad R. Abuzinadah, MBBS No disclosure on file
Kate M. Essad, MD, FAAN Dr. Essad has nothing to disclose.
Melanie Glenn, MD No disclosure on file
Asli Tuncer No disclosure on file
Virginia Laura Parisi, MD No disclosure on file
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Jennifer Neureiter No disclosure on file
Maria Cerdan Sanchez No disclosure on file
Ester Carreon Guarnizo Ester Carreon Guarnizo has nothing to disclose.
Patricio Labal, MD, PhD No disclosure on file
Elizabeth H. Wise, APRN Ms. Wise has nothing to disclose.
Jorge Blanche, MD No disclosure on file
Jun Hong Lee, MD No disclosure on file
Clarisse Carra-Dalliere No disclosure on file
Philip G. Eye, MD No disclosure on file
Anna Pink, PhD No disclosure on file
Francisco J. Varela, MD Dr. Varela has nothing to disclose.
Abdulaziz Alsaman No disclosure on file
Tapan Abrol, MD No disclosure on file
Silvia Christiansen No disclosure on file
Julien Bonenfant No disclosure on file
Birinder S. Paul, MD Dr. Paul has nothing to disclose.
Monika Singla, MBBS Dr. Singla has nothing to disclose.